Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Humulin R U-500 Generic Name & Formulations
Legal Class
Rx
General Description
Regular insulin (human, rDNA origin) 500 Units/mL; inj; contains m-cresol.
How Supplied
Vials 70/30, N, R (U-100)—3mL, 10mL; R (U-500)—20mL; KwikPen (70/30, N)—5x3mL; R (U-500)—2x3mL
Manufacturer
Humulin R U-500 Indications
Indications
Diabetes.
Humulin R U-500 Dosage and Administration
Adults and Children
Individualize. SC inj only. Rotate inj sites. Onset ~30mins, peak 4–8hrs, duration up to 24hrs. Should prescribe U-500 insulin syringes for use with Humulin R U-500 vials.
Humulin R U-500 Contraindications
Contraindications
During episodes of hypoglycemia.
Humulin R U-500 Boxed Warnings
Not Applicable
Humulin R U-500 Warnings/Precautions
Warnings/Precautions
Instruct patients on proper administration of insulin, check insulin label before each injection, and management of hypoglycemia. Do not reuse or share pens, needles, or syringes between patients, even if the needle is changed. Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis. Increased risk of hyperglycemia or hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site, and if acute illness occurs: monitor glucose more frequently and may need to adjust dose. Monitor potassium levels in patients at risk for hypokalemia (eg, concomitant K+-lowering or K+-sensitive drugs). Discontinue if hypersensitivity reactions occur. Renal or hepatic impairment. Elderly. Pregnancy. Nursing mothers.
Humulin R U-500 Pharmacokinetics
See Literature
Humulin R U-500 Interactions
Interactions
Concomitant thiazolidinediones (TZDs) may cause fluid retention and heart failure; consider dose reduction or discontinue TZDs. Increased risk of hypoglycemia with concomitant antidiabetics, ACEIs, ARBs, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (eg, octreotide), sulfonamide antibiotics. Reduced efficacy with concomitant atypical antipsychotics (eg, olanzapine, clozapine), steroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, protease inhibitors, somatropin, sympathomimetics (eg, albuterol, epinephrine, terbutaline), thyroid hormones. Variable effects with β-blockers, clonidine, lithium salts, alcohol, pentamidine. Concomitant β-blockers, clonidine, guanethidine, reserpine may blunt hypoglycemia. Onset may be delayed if regular insulin is mixed with zinc insulin. Regular and NPH insulins may be mixed and used immediately or stored for future use.
Humulin R U-500 Adverse Reactions
Adverse Reactions
Hypoglycemia, allergic reactions, inj site reactions, lipodystrophy, pruritus, rash, weight gain, edema, hypokalemia.
Humulin R U-500 Clinical Trials
See Literature
Humulin R U-500 Note
Not Applicable
Humulin R U-500 Patient Counseling
See Literature
